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Synthesis of remn by tubulocystic epithelium in autosomal.dominant
polycystic kidney disease. Evidence suggests an important role for the
renin-angiotensin system in the pathogenesis of autosomal-dominant
polycystic kidney disease (ADPKD). Therefore, we studied the pres-
ence of immunoreactive renin in renal biopsies and measured the
concentrations of renin in cyst fluids. Normal kidneys and kidneys with
renal artery stenosis were used for comparison. In ADPKD, immuno-
reactive renin was present in juxtaglomerular apparatus, associated
arterioles, and in some cells within the connective tissue surrounding
the cysts. Vascular immunoreactive renin was less prominent than in
renal artery stenosis. Increased amounts of tubular immunoreactive
renin were noted in polycystic kidneys, as compared to normal kidneys
and kidneys with renal artery stenosis. Cyst fluids contained renin
detected by Western analysis and enzymatic activity; concentrations
were greater in gradient cysts than in nongradient cysts. Seventy-four
percent of the renin in gradient cysts was active as compared to 23% in
nongradient cysts and 15% in plasma. To determine whether cyst
epithelial cells are capable of synthesizing renin, these cells were
isolated in tissue culture. Enzymatic assay of extracts from these cells
revealed the presence of renin-like enzymatic activity (1.3 0.8 ng
Al/mg protein/hr). The synthesis of renin by tubulocystic epithelium
was confirmed by [35S]-methionine radiolabeling of cyst-derived cells,
followed by immunoprecipitation and SDS-PAGE and by detection of
renin mRNA by the polymerase chain reaction, These results indicate
that the tubulocystic epithelium has the potential to synthesize renin.
Elevated levels of active renin in renal cysts may be linked to the
pathogenesis of hypertension in ADPKD. The occurrence of renin in
the lining epithelium of cyst walls raises the possibility that abnormal
expression of the renin.angiotensin system may, by a paracrine or
autocrine mechanism, regulate epithelial hyperplasia in growing renal
cysts.
Autosomal-dominant polycystic kidney disease (ADPKD) is
a common inherited disease, often with associated hyperten-
sion, characterized by hyperplasia of the tubular epithelium and
progressive cystic transformation and enlargement of the kid-
neys [1—4]. An altered synthesis of or sensitivity of the tubular
epithelial cells to peptide growth factors, such as epidermal
growth factor (EGF), is suspected to be one of the basic
mechanisms underlying hyperplasia of the cyst lining epithe-
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hum in ADPKD [5—7]. As angiotensin II is a growth factor in
many cell systems [8—14] and renal cystogenesis induced by
2-amino-4-5 diphenyithiazole is enhanced by conditions that
activate and lessened by interventions that suppress the renin-
angiotensin system [15], it has been proposed that the intrarenal
angiotensin system may modulate the process of cyst formation
in ADPKD [15]. In addition, it has become increasingly appar-
ent that a hyperactivity of the renin-angiotensin system within
the kidney contributes significantly to the high renal vascular
resistance and abnormal renal sodium handling which lead to
the development of hypertension in this disease [16—18]. De-
spite the prominent role that the intrarenal renin-angiotensin
system may play in the pathogenesis of ADPKD, there is only
sparse information on the presence and distribution of renin in
the kidneys of patients with this disease [19].
Methods
Patients and materials
Renal cyst fluids were obtained from ADPKD patients who
underwent a bilateral nephrectomy prior to renal transplanta-
tion (N = 2), percutaneous cyst aspiration (N = 2), or surgical
cyst decompression (N 6). Of these patients, three had
normal renal function [serum creatinine (Sr) 0.9 to 1.1 mg/dl],
three had mild renal insufficiency (Sr 1.4 to 1.8 mgldl), and four
had advanced renal insufficiency (Sr> 3 mg/dl). None of the
patients in this study were treated with converting enzyme
inhibitors. The renal cyst fluids were classified according to
their sodium concentration into gradient (<120 mEq/liter) and
nongradient cyst fluids ( 120 mEq/liter). Hepatic cyst fluids
were obtained from ADPKD patients with massive polycystic
liver disease who underwent partial hepatectomy (N = 5).
Blood samples for determinations of plasma renin concentra-
tion were obtained from untreated hypertensive ADPKD pa-
tients with normal renal function after remaining for two hours
in an upright position. Formalin fixed, paraffin-embedded tissue
blocks from polycystic kidneys obtained at the time of unilat-
eral (N = 4) or bilateral (N = 11) nephrectomy were used for
immunohistochemical studies. The indications for surgery were
hemorrhage in three patients and preparation for renal trans-
plantation in 12 patients. Of these patients, one had normal
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ical studies. Renal cyst walls obtained at the time of surgical
decompression of polycystic kidneys or nephrectomy were
used to grow cyst-derived epithelial cells in culture.
Measurements of active and inactive renin
Determinations of renin were performed by measurements of
enzymatic activity. Active renin was measured using a modifi-
cation of the method of Haber et al [20]. The renin concentra
tion was determined by addition of semipurified sheep angio-
tensinogen as substrate (1,000 ng of angiotensin I releasing
Torres et a!: Tubular renin in ADPKD 365
Fig. 1. Pepstatin agarose chromatography with lithium bromide gradient elution and Western immunoblot of pooled renal cyst fluids using rabbit
anti-human renin antiserum (left panel) or rabbit anti-human renin antiserum preabsorbed with human kidney renin (right panel). The antirenin
antibodies recognize two proteins with apparent molecular weights of 55 KD and 40 KD.
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renal function (Sr 1 mg/dl), ten had advanced renal insuffi-
ciency (Se,. 4 to 13 mg/dl), and four had been dialyzed for
periods ranging between two months and two years. All but one
of these patients had a history of hypertension and had been
treated with antihypertensive or diuretic medications. None
had received converting enzyme inhibitors during the six
months preceding the nephrectomy. Tissue blocks from kid-
neys with renal artery stenosis obtained at the time of nephrec-
tomy or revascularization and from normal areas of kidneys
with renal cell carcinoma were also used for immunohistochem-
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Fig. 2. Concentrations of total, active, and
inactive renin in plasma, gradient and
non gradient renal cyst fluids, and hepatic cystP G NG H fluids obtained from patients with ADPKD.
Abbreviations are: F, plasma; G, gradient;
Inactive NG, nongradient; H, hepatic; *-*, P < 0.05.
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Fig. 3. Correlation between the sodium concentration and the percent
of total renin that was active in the renal cysifluids. r = 0.70; P < 0.001.
activity) [21]. Angiotensin I was measured by radioimmuno-
assay. Inactive renin was measured by converting it to active
renin using trypsin. To determine the optimal concentration of
trypsin, aliquots of cysts fluids or plasma were incubated with
increasing concentrations of trypsin at 37°C for one hour. The
reaction was stopped by adding 10 il of a solution of 50 mg/mi
phenylmethylsuiphonylfluoride (PMSF) and 1 pJ of 0.25 M
maleic acid. By using this approach, we found that the concen-
tration of trypsin of 0.15 mg/mi for cyst fluids and of 1.50 mg/mi
for plasma resulted in maximum activation of renin. Lower
concentrations resulted in incomplete activation while higher
concentrations resulted in decreases in the renin activity,
suggesting degradation. The optimal concentration of trypsin
was therefore used to measure inactive renin.
Immunoblotting
The presence of renin in the cyst fluids was also studied by
Western analysis [22]. Cyst fluid samples were analyzed by
sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) on 10% gels under reducing conditions and trans-
ferred to nitrocellulose membranes. The membranes were
blocked for three hours with 0.05% Tween-20 in tris-buffered
saline (TBS, 0.1 M NaCl, 0.05 M tris[hydroxylmethyi]ami-
nomethane, pH 7.5) and then reacted for two hours with rabbit
anti-human renin diluted in TBS/1% bovine serum albumin/
0.1% normal goat IgG. Control membranes received an equal
concentration of normal rabbit serum. The membranes were
then washed with TBS/Tween-20 and reacted with alkaline
phosphatase-labeled goat anti-rabbit IgG (Sigma Chemical Co.,
St. Louis, Missouri, USA), washed, and developed with fast
red-violet (Sigma). In some experiments, human kidney renin
(10 mg/mI, Calbiochem, La Jolla, California, USA) was in-
cluded in the incubation with primary antibody to block specific
interactions,
Isolation of cyst fluid renin
Pooled cyst fluid samples were precipitated for 12 hours at
4°C with 65% saturated ammonium sulfate, the pellets redis-
solved, and then dialyzed into 0.005 M sodium acetate, pH 5.5.
This material was applied to a 4 ml of pepstatin-agarose (Sigma)
column and eluted with a gradient of LiBr (0 to 0.5 M) in 0.05 M
tris, pH 7.50 [23]. Gradient fractions were processed for immu-
noblotting as described above.
Fig. 4. Sections of a polycystic kidney stained by the PAP method with
rabbit antirenin human antibodies. Renin positivity in the juxtaglomer-
ular apparatus (A), arteriole (B), small artery (C), and cells within the
connective tissue surrounding a cyst (D). Publication of illustrations in
color was made possible by a grant from Merck, Sharp and Dohme.
Im,nunohistochemicai studies
Four micron tissue sections of the different blocks were
stained by the use of polyclonal rabbit anti-human renin anti-
bodies and a peroxidase-antiperoxidase (PAP) immunohistol-
ogy staining kit (Histogen PAP Universal Kit, Biogenics Lab-
oratories, Dublin, California, USA) [15]. Negative controls
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Fig. 6. Sections of a normal kidney (A) and a kidney with a renal artery stenosis (B), and serial sections of a polycystic kidney (C andD) stained by the
PAP method with rabbit anti-human renin antiserum (A, B and C) or rabbit anti-human renin antiserum preabsorbed with human kidney renin (D).
Prominent staining seen injuxtaglomerular apparatus and arterioles of the kidney with renal artery stenosis (A). The renin immunostaining in dilated
tubules and epithelium lining a cyst in the polycystic kidney (C) is completely blocked by preabsorption of the antiserum with human kidney renin (D).
Publication of illustrations in color was made possible by a grant from Merck, Sharp and Dohme.
included sections incubated with nonimmune rabbit gamma ity of the renin antibody has been previously reported [241. The
globulin and with the polyclonal rabbit anti-human renin anti- total number ofjuxtaglomerular apparatus and of small arteries
serum preabsorbed with human kidney renin. The renin antise- and arterioles without demonstrated connection to the glomer-
rum recognizes both active and inactive renin and the specific- ulus, containing cells with renin immunoreactivity, were
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Fig. 7. Serial sections of a polycystic kidney stained by the PAP method with antibodies to human renin ('A), lysozyme (B), Tamm-Horsfall protein
(C), and epidermal membrane antigen (D). The epithelial cells lining a cyst are positive for renin and epidermal membrane antigen. Publication of
illustrations in color was made possible by a grant from Merck, Sharp and Dohme.
counted and factored by the total number of glomeruli in each
tissue section. The tubular staining for renin was semiquantita-
lively graded on a scale of 0 to 3 (0 absent, 1 to 3 some tubular
staining noticeable in <5%, 5 to 20%, and over 20% of at least
20 randomly selected fields at 100 x magnification). Similar
scores were obtained by two independent observers. Serial
sections were also stained for tubular markers including lyso-
zyme for the proximal tubule (Bio Genex, San Ramon, Califor-
nia, USA) [25], Tamm-Horsfall protein for the thick ascending
loop (Cortex Biochem, San Leandro, California, USA) [261,
and epidermal membrane antigen for the distal tubular and
collecting ducts (Bio Genex) [27]. Cyst-derived epithelial cells
(see below) subcultured on Lab-Tek tissue culture slides (Nunc,
Naperville, Illinois, USA) were fixed in 70% ethanol and
stained for cytokeratin AE- 1 (Signet, Dedham, Massachusetts,
USA) [28] and renin.
Isolation of cyst-derived epithelial cells
Surgical specimens were transported to the laboratory in
sterile saline. The cyst walls were dissected free, washed in
serum-free medium, and digested in 0.6% collagenase (Boehr-
inger Mannheim, Indianapolis, Indiana, USA) in Earle's bal-
anced salt solution for one hour at 37°C. The cells were then
washed twice in medium 199/10% fetal bovine serum (both from
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Fig. 9. Immunoprecipitation and SDS-PAGE of supernatants of [35S]-
methionine labeled cyst-derived epithelial cells cultured in the presence
(FBS), and absence (SF) of 10% fetal bovine serum. The main synthe-
sized protein immunoprecipitated by anti-human renin antibodies has
an apparent molecular weight of 55 KD.
Fig. 8. Cyst-derived epithelial cell culture stained by the PAP method
with normal rabbit gamma globulin (A), antibodies to cytokeratin AE-1
(B), and rabbit anit-human renin antiserum (C). Publication of illustra-
tions in color was made possible by a grant from Merck, Sharp and
Dohme.
Hyclone, Logan, Utah, USA) and inoculated into tissue culture
flasks (Falcon, Oxnard, California, USA). Cultures were fed
twice weekly with fresh medium 199/10% fetal bovine serum,
supplemented with 100 U/mi penicillin G and 20 g/ml genta-
micin. When confluent, cells were passaged with trypsin/EDTA
(GIBCO/BRL, Gathersburg, Maryland, USA). All cells for
these experiments were used at first or second passage.
Radiolabeled biosynthesis
Endogenous renin synthesis was evaluated by incubation of
70% confluent, quiescent cells for 12 hours in medium 199/10%
fetal bovine serum containing 80 CiIml [35Sjmethionine (Am-
ersham, Arlington Heights, Illinois, USA) and 50 U/mi Aproti-
nm A (Sigma). At the end of the labeling period, the medium
was collected and precipitated with 50% saturated ammonium
sulfate for 12 hours at 4°C. The precipitates were pelleted,
dissolved in TBS made 0.002 Mphenyimethylsulfonyl fluoride,
pH 7.40, and then exhaustively dialyzed against the same buffer
at 4°C. To reduce nonspecific interactions, the samples were
first pre-cleared by incubation with normal rabbit serum for 12
hours at 4°C, followed by protein A-Sepharose (Sigma). The
supernatants of these preincubations were then incubated with
rabbit anti-human renin antiserum for 12 hours at 4°C, the resin
pelleted and washed with buffer, and bound immunoprecipi-
tates released with 2% sodium dodecyl sulfate. Samples were
then analyzed by SDS-PAGE on 10% gels under reducing
conditions, followed by fluoro-autoradiography of the dried
gels.
Determinations of renin mRNA
These determinations were done with the use of mRNA
isolated from cultured cells at 70% subconfluence. Freshly
isolated normal human kidney cortex and a human myeloma
cell line were used as positive and negative controls. The
Microfast Track Kit was used to extract the poly A + mRNA as
described by the manufacturer (Invitrogen, Inc.). The standard
reaction mix from Amersham was used for first cDNA strand
synthesis. A polymerase chain reaction (PCR) assay with
primers from renin exons 7 (5'GGTGTCTGTGGGGTCAT-
CCA3') and 8 (5'CTGAAATACATAGTCCGCGC3') was then
used to look for the presence of renin mRNA. Primers from two
different exons were utilized to distinguish the mRNA amplified
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FIg. 10. Detection of PCR amplified renin mRNA fragments (double arrow) in cyst-derived cultured epithelial cells (lanes 3 to 6). Other lanes: 1-2,
renal cortex mRNA; 7, normal genomic DNA; 8, myeloma cell line mRNA. PCR amplified renin DNA fragments (single arrow) were detected in
the normal genomic DNA control and, as contaminants, in some of the mRNA extracts.
fragment from fragments that might have been generated from
contaminating DNA in the mRNA samples. The PCR was
carried out with the use of Thermus aquaticus DNA polymerase
for 30 cycles under the following conditions: denaturation for
one minute at 94°C, annealing for two minutes at 60°C, and
extension for two minutes at 72°C. Controls included normal
human genomic DNA and a no DNA sample. Additional control
PCRs were run using primers to the Actin gene (S'GCTCCG-
GCATGTGCAA) (3'AGGATCflCATGAGGTAGT) (a gift from
Dr. R. Horton, University of Minnesota, Minneapolis, Minnesota,
USA) and conserved regions of the HLA A2 gene (5'GCTACTA-
CAACCAGAGCGAOGCCG) (3'GCCATGTCCGCCGCGGTC-
CCA) (a gilt from Dr. L. R. Pease, Mayo Clinic, Rochester,
Minnesota, USA). PCR products were analyzed on ethidium
stained agarose gels. Southern blot analysis of the PCR amplifica-
tion products of renin mRNA and genomic DNA was performed
using a renin specific cDNA [29], In addition, sequence analyses
of the PCR products generated from the normal kidney and cyst
mRNA and from genomic DNA samples were performed to
compare the products to the previously sequenced renin gene [30].
Sequence analyses were done using the Sanger dideoxy chain
termination method. In order to generate sufficient product for
sequencing, the PCR products were reamplified. Amplified DNA
was then purified by Geneclean (BIO, 101, La Jolla, California,
USA) following agarose gel electrophoresis, denatured and an-
nealed to a 32P-end labeled primer. The template-primer mixture
was aliquotted into four tubes containing deoxy and dideoxy
nucleotides, 0.5 j.tl of 0.1 M dithiothreitol and 1 U sequenase (U.S.
Biochemical, Cleveland, Ohio, USA). The reaction was termi-
nated after five minutes at 37°C, heated to 95°C for two minutes,
chilled and electrophoresed on a 6% polyacrylamide/7 M urea gel
at 50°C for one to two hours at 70 watts. Alter drying, the gels
were exposed to Kodak X-ARS film at RT with the use of
intensifying screens.
Statistical analysis
Comparisons between the groups were made using the it-test
for unpaired observations or the rank-sum test as appropriate.
All P values reported were two-tailed, and the conventional
cut-off of 0.05 was taken to reflect statistical significance.
Results
The renal cyst fluids contained renin detectable by both
Western analysis and enzymatic activity. Virtually no renin was
detectable by either method in the hepatic cyst fluids. On the
Western blot analysis of renal cyst fluid, the rabbit anti-human
renin antiserum recognized a protein with an approximate
molecular weight of 55 kD. A second band with an approximate
molecular weight of 40 kD was detected in some cyst fluids. The
elution characteristics of these proteins on pepstatin agarose
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chromatography with lithium bromide gradient were identical to
those described for renin (Fig. 1). The staining of these proteins
could be blocked by preabsorption of the antiserum with human
kidney renin (Fig. 1).
The concentrations of total renin, measured by enzymatic
activity, in the renal gradient cyst fluids were significantly
higher than in the nongradient cyst fluids (Fig. 2), while the
protein concentrations were similar. The concentrations of
active renin were significantly higher in the renal gradient cyst
fluids as compared to both nongradient cyst fluids and plasma.
Seventy-five percent of the renin in the gradient cyst fluids was
active as compared to 23% in the nongradient cyst fluids and
15% in the plasma (P <0.001). There was a highly significant
negative correlation between the sodium concentration and the
percent of total renin that was active in the fluids from the renal
cysts (Fig. 3). There was no consistency in the concentration of
renin among cyst fluids from the same patient. No correlation
between cyst fluid renin concentrations and levels of renal
function was detected.
In some polycystic kidneys, immunoreactive renin was de-
tectable not only in the juxtaglomerular apparatus, but also
extending into the renal arterioles and small arteries and within
cells in the connective tissue surrounding the cysts (Fig. 4).
Although the percent of juxtaglomerular apparatus and arteri-
oles containing renin tended to be higher in the polycystic
kidneys than in the normal kidneys, this difference was not
statistically significant (Fig. 5). The arteriolar/JGA renin score
was much lower in the polycystic kidneys than in the kidneys
with renal artery stenosis (Figs. 5 and 6).
A conspicuous feature in many polycystic kidneys was the
substantial amount of immunoreactive renin in dilated tubules
and cysts (Fig. 6). This tubular staining was detected at low
dilutions of the primary antibody (1:50 to 1:200). The immuno-
staining was attenuated and eventually abolished by progres-
sive dilution of the antiserum and could be completely blocked
by preabsorption of the antiserum with human kidney renin
(Fig. 6). Most of the tubules containing renin were proximal
tubules, as indicated by the positive lysozyme staining, but
many cysts of distal origin, as indicated by positive epidermal
membrane antigen staining, also contained renin (Fig. 7). The
main distinction between the polycystic and the non-polycystic
kidneys was the degree of tubular staining rather than the extent
of vascular staining (Fig. 5). There was no detectable correla-
tion between the degree of tubular staining and the status of the
patient from whom the tissue was obtained.
Cyst-derived epithelial cell cultures stained positively for
cytokeratin AE-l, an epithelial cell marker, and for renin. The
pattern of staining of these two proteins was different (Fig. 8).
Assays of enzymatic activity in sonicated cyst-derived epithe-
hal cell cultures revealed the presence of low levels of renin-hike
enzymatic activity (1.3 0.8 ng Al/mg proteinlhr). Radiolabel-
ing of cyst-derived cells in culture with [35S}methionine fol-
lowed by immunoprecipitation and SDS-PAGE revealed the
presence of a newly synthesized protein with an apparent
molecular weight of 55 kD which was immunoprecipitated by
rabbit antihuman renin antiserum (Fig. 9).
Renin mRNA was consistently detected by PCR in cyst-
derived epithelial cell cultures as shown by the presence of a
fragment of predicted size (241 bp) (Fig. 10). Further confirma-
tion that the PCR amplified material was in fact derived from
renin mRNA was provided by Southern hybridization with a
renin-specific cDNA probe, and, more importantly, the demon-
stration of the sequence corresponding to exons 7 and 8 of the
human renin gene. Control PCRs using primers to the actin and
the HLA-A2 genes generated similar amounts of product from
these cyst-derived cultures (results not shown) despite the
varying levels of renin mRNA (Fig. 10), and also demonstrated
the presence of intact mRNA in the human myeloma cell line
(negative renin mRNA control).
Discussion
The results of our study confirm the observations by Graham
and Lindop of a shift of immunoreactive renin in ADPKD from
the juxtaglomerular apparatus to the walls of the arterioles and
small arteries and of renin containing cells embedded in con-
nective tissue surrounding the cysts in some polycystic kidneys
[19]. These authors suggested that the abnormal distribution of
these renin-containing cells in ADPKD could affect both the
intrarenal action of renin and its access to the circulation.
The results of our study also suggest that the tubulocystic
epithelium has the potential to synthesize renin. It seems
unlikely that the presence of renin in the renal cyst fluids in
ADPKD is exclusively due to glomerular filtration or diffusion
from the renal interstitium. Since most cysts measuring more
than 2 mm in diameter are disconnected from the nephrons from
which they originate [31], glomerular filtration cannot account
for the presence of renin in these cysts. Since the epithehium
lining the gradient cysts is much less permeable than that lining
the nongradient cysts [32] and concentrations of beta-2 micro-
globulin [33] and erythropoietin [34] are much higher in nongra-
dient cysts than in gradient cyst fluids, diffusion from the renal
interstitium cannot explain the higher concentration of renin in
the gradient cyst fluids. It also seems unlikely that the immu-
nohistochemical demonstration of renin in dilated tubules and
cysts can be explained by reabsorption of filtered renin, as the
kidneys with renal artery stenosis had less immunoreactive
renin in the tubules, despite prominent staining of juxtaglomer-
ular apparatus and arterioles and presumably high levels of
circulating renin. The demonstration that cyst-derived epithelial
cells in culture express renin mRNA and synthesize renin
suggests that the renin detected in some cyst fluids and tubular
epithehial cells is produced by the tubulocystic epithelium.
These observations raise the possibility that tubular renin may
affect, in an autocrine or paracrine fashion, the process of
epithelial cell hyperplasia and cyst formation, as well as con-
tribute to the pathogenesis of hypertension in ADPKD.
While most of the renin in the plasma and nongradient cyst
fluids is inactive, 74% of the renin in the gradient cysts is active.
Although active renin could be the primary product of secretion
of the tubulocystic epithelium lining the gradient cysts, it seems
more likely that the activation of renin occurs in the cyst fluid
by the action of proteases such as cathepsin B, kallikrein, or
others [35]. Since angiotensin II has been found to stimulate
sodium and bicarbonate reabsorption in some tubular segments
[36—40], the possibility that the activation of renin could con-
tribute to the low sodium and bicarbonate concentrations
characteristic of the gradient renal cyst fluids cannot be dis-
missed.
The synthesis of renin by the tubular epithelium is not unique
to ADPKD. For some time the demonstration of renin by
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immunohistochemical techniques in the proximal, connecting,
and cortical collecting tubules, both in adult and fetal kidneys,
was thought to be exclusively due to reabsorption of filtered
renin [41—44]. Initially, the finding of renin mRNA in the renal
medulla was thought to be due to cortical contamination [45].
More recently, it has been reported that cultured proximal
tubule cells contain renin mRNA and release an enzyme with
renin-like activity into the medium [46—49]. Furthermore, it
appears that this synthesis occurs in a regulated manner, being
stimulated by forskolin, isoproterenol, and sodium-free me-
dium, and inhibited by ouabain. The demonstration of renin
mRNA in the distal and collecting tubules by in situ hybridiza-
tion [50] also suggests that other tubular segments can synthe-
size renin. Our study extends these observations to the tubulo-
cystic epithelium. Since the tubular origin of the cyst-derived
epithelial cells in culture is difficult to characterize, we have not
compared the production of renin by these cells with that by
cultured cells derived from normal tubular segments. Neverthe-
less, the results of our immunohistochemical study suggest that
the synthesis of renin by the tubulocystic epithelium may be
particularly active and deserves further consideration.
The proliferation of tubuloepithelial cells, which is of funda-
mental importance in the pathogenesis of ADPKD [5—7], is
regulated by a variety of growth factors. Peptide growth factors
that stimulate the proliferation of tubular epithelial cells include
epidermal growth factor (EGF), insulin-like growth factors
(IGF-l and IGF-2) and platelet-derived growth factor (PDGF)
[51—53]. On the other hand, transforming growth factor beta
(TGF-/3) has an inhibitory effect, transforming the mitogenic
response to EGF into a hypertrophic response [54]. Angiotensin
II is an important growth factor in a variety of organs and
cultured cell systems [8—14]. It induces the expression of
protooncogenes c-phos, c-myc, c-ras, and EGR-1, among other
genes, stimulates protein synthesis and secretion of type IV
procollagen, and induces cellular hypertrophy in murine prox-
iinal tubule cells [55—59]. By itself, however, angiotensin II has
not been found to be mitogenic on either murine or rabbit
culture proximal tubular cells. Nevertheless, preincubation of
these cells with angiotensin II strongly potentiates the mitoge-
nic effect of EGF [59—60] and transfection of proximal tubular
cells with c-mas oncogene changes the hypertrophic effect of
angiotensin II into a proliferative response [61]. Whether angio-
tensin II may affect cell proliferation resulting in hyperplasia of
the tubulocystic epithelium in ADPKD is not known.
Finally, it has become increasingly apparent that the renin-
angiotensin system plays a major role in the pathogenesis of the
hypertension associated with ADPKD [16—18]. At present, the
mechanisms responsible for the hyperactivity of intrarenal
renin-angiotensin system in ADPKD are unclear [18]. Whether
the tubular renin reported in this study is of any pathophys-
iological significance for the development of hypertension in
ADPKD is uncertain,
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